인쇄하기
취소

MFDS designations of 4 additional orphan drugs including lung cancer therapy ‘Brigatinib’

Published: 2017-12-28 16:27:10
Updated: 2017-12-28 16:27:23

4 medicines, including ‘Brigatinib,’ a targeted therapy for lung cancer, were designated as orphan drug.

The Ministry of Food and Drug Safety(MFDS) pre-announced the ‘Partial Revision Bill to Regulations of Orphan Drugs,’ which newly designated total 4 substances as orphan drug and add and change target diseases/disorders on 5 existing orphan drugs.

The substances newly added as orphan drug a...

Fees

- Email service daily and homepage access.
  1. $300 per month.
  2. 5 Email holders per each company.
  3. Anual contract base.
Copyright Yakup.com All rights reserved.
약업닷컴의 모든 컨텐츠는 저작권법의 보호를 받습니다. 무단 전재⋅복사⋅배포 등을 금합니다.